تخطي إلى المحتوى الرئيسي

Congenital dyserythropoietic anaemia

Congenital dyserythropoietic anaemia (CDA) is a rare group of inherited blood disorders that affects the development of red blood cells. In people with CDA, immature red blood cells do not develop into normal, mature cells. As a result, affected individuals have a significant reduction in the number of functional red blood cells (anaemia). The term "dyserythropoietic" refers to the abnormal red blood cell shape that occurs in people with this condition. People with CDA typically have mild to moderate anaemia. In some cases, affected individuals have severe anaemia that may require frequent blood transfusions to replenish the supply of red blood cells.

الوصف

Congenital dyserythropoietic anaemia (CDA) is a rare group of inherited blood disorders that affects the development of red blood cells. In people with CDA, immature red blood cells do not develop into normal, mature cells. As a result, affected individuals have a significant reduction in the number of functional red blood cells (anaemia). The term "dyserythropoietic" refers to the abnormal red blood cell shape that occurs in people with this condition. People with CDA typically have mild to moderate anaemia. In some cases, affected individuals have severe anaemia that may require frequent blood transfusions to replenish the supply of red blood cells.

The signs and symptoms of CDA can include tiredness (fatigue), weakness, yellowing of the skin and eyes (jaundice), and an enlarged liver and spleen (hepatosplenomegaly). CDA also causes the body to absorb too much iron (iron overload), which can damage tissues and organs.

There are multiple types of CDA. Each type has a different genetic cause and distinct but overlapping patterns of signs and symptoms.

CDA type I is characterised by moderate to severe anaemia that typically begins in childhood or adolescence, although the condition can be detected before birth in some cases. In addition to the signs and symptoms common to all types of CDA, individuals with CDA type I can have skeletal issues, including short stature or abnormalities of the fingers or toes.

The anaemia associated with CDA type II can range from mild to severe, and it usually develops in adolescence or early adulthood. Individuals with CDA type II may develop hard deposits in the gallbladder called gallstones in addition to the usual signs and symptoms of CDA.

CDA type III can result in anaemia that ranges from mild to severe, depending on the genetic cause, and typically begins in infancy or childhood. Some people with CDA type III do not receive a diagnosis until later in life because they have very mild symptoms. In some cases, individuals with CDA type III develop a blood disorder known as monoclonal gammopathy, which can lead to a cancer of white blood cells (multiple myeloma). Some people with CDA type III have eye abnormalities that can cause vision impairment.

CDA type IV is characterised by moderate to severe anaemia that typically develops early in life, although the condition can be detected before birth in some cases. Affected individuals can have extensive swelling caused by fluid accumulation before birth (hydrops fetalis). In addition to the signs and symptoms that are common to all types of CDA, individuals with CDA type IV often have short stature.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal recessive; Autosomal dominant+1 affected parent. More than one pattern can apply in different cases.

Other names

Anaemia, dyserythropoietic, congenital

CDA

congenital dyserythropoietic anaemia

Related patient information and medicines

تكور الدم الوراثي

Patient information leaflet

تكور الدم الوراثي

Hereditary spherocytosis (HS) هو inherited condition of red blood cells. The disease can be mild and go unrecognised in some people. What is hereditary spherocytosis. Hereditary spherocytosis (HS) هو an inherited condition that affects your red blood cells. The red blood cells are those that carry oxygen around the body. What are the features.

صفة الخلية المنجلية

Patient information leaflet

صفة الخلية المنجلية

If you inherit a gene from one of your parents, called a sickle cell gene, you have a condition called sickle cell trait. If you inherit a sickle cell gene from both parents, you get a double dose of the sickle cell gene. This causes a condition called sickle cell disease (SCD). What is sickle cell trait. صفة الخلية المنجلية means having one gene.

مرض الخلايا المنجلية

Patient information leaflet

مرض الخلايا المنجلية

صفة الخلية المنجلية is not the same as sickle cell disease. Sickle cell disease Sickle cell disease (SCD) is a serious group of conditions which are inherited (genetic). It affects the red blood cells in the blood. Sickle cell anaemia is the name of a specific form of sickle cell disease in which there are two sickle cell genes (see below). What is.

متلازمة أوسلر-ويبر-ريندو

Patient information leaflet

متلازمة أوسلر-ويبر-ريندو

متلازمة أوسلر-ويبر-ريندو is a disorder of the دم vessels that can cause excessive bleeding. متلازمة أوسلر-ويبر-ريندو is also called hereditary haemorrhagic telangiectasia. The abnormal blood vessels can cause bleeding both into the skin and inside your body. What is Osler-Weber-Rendu syndrome. People with Osler-Weber-Rendu syndrome can.

فقر الدم

Patient information leaflet

فقر الدم

فقر الدم means that you have fewer red blood cells than normal or تعتقد have less haemoglobin than normal in each red blood cell. In either case, a reduced amount of oxygen is carried around in the bloodstream. Anaemia types and causes Iron-deficiency anaemia Lack of iron is the most common type of anaemia in the UK. This is called iron-deficiency.

الثلاسيميا

Patient information leaflet

الثلاسيميا

Thalassaemia is an inherited condition affecting the blood. For the more severe forms of thalassaemia, modern treatment gives a good outlook, but lifelong monitoring and treatment are needed. What is thalassaemia. Thalassaemia is an inherited (genetic) condition affecting the blood. There are different types of thalassaemia. Depending on which.

قراءة إضافية ومراجع

تاريخ المقال

تمت كتابة المعلومات على هذه الصفحة ومراجعتها من قبل أطباء مؤهلين.
  • 4 مارس 2025 | أحدث إصدار
  • 1 مارس 2025 | نُشر في الأصل

انضم إلى المحادثة

شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.

تنويه: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
أداة التحقق من أهلية لقاح الإنفلونزا

اسأل، شارك، تواصل.

تصفح المناقشات، اطرح الأسئلة، وشارك التجارب عبر مئات المواضيع الصحية.

اشترك في النشرة الإخبارية للمرضى

جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.

يرجى إدخال عنوان بريد إلكتروني صالح

من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.